Statistical methods in clinical trials
Author: Peter J Goadsby
Published online: 21 July 2003
Peter J Goadsby
Professor of Clinical Neurology, Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen's Square, London, WC 1N 3BG, United Kingdom
To the Editor: Gebski and Keech describe with clarity and accuracy the important basic concepts of statistical analysis for physicians.1 I would like to draw attention to two issues.
Firstly, the authors refer to common measurement scales that are used in medicine. It is crucial to understand the limits of a measurement to begin to appreciate results from any study. They describe the continuous scale and offer blood pressure and temperature measurements as examples. This scale refers to data determined such that the distance between any two points is known and measureable. Siegel used the term "ratio scale" if there was a true zero point to the measurement.2 This contrasts to an ordinal categorical scale, in which the intervals are not constant. The scale referred to can be transformed, and is anchored with respect to the measurements to some reproducible point. The term "ratio" for this scale seems preferable, as the world is, in essence, discrete when measured, in the quantum sense. Certainly, the measured world is not continuous, at least as far as we can determine it.
Secondly, the authors do not mention resampling methods.3 These can be very powerful and are attractive in biomedical research when the distribution may not be defined. While I realise these methods are relatively new, they do seem unreasonably ignored in undergraduate medical education.
References
- Gebski VJ, Keech AC. Statistical methods in clinical trials. Med J Aust 2003; 178: 182-184. <eMJA full text>
- Siegel S. Non-parametric statistics for the behavioural sciences. Kogakusha, Tokyo: McGraw-Hill, 1956. i1082459
- Kaplan DT. Resampling stats in MATLAB. Arlington, Virginia: Resampling Stats, Inc., 1999. i1082461
Interpreting Australian Stillbirth Rate Trends: Implications for Surveillance and Continuous Quality Improvement
Aleena M. Wojcieszek, Kirstine Sketcher-Baker, Christine Andrews, Michael Coory, Imogen Kettle, Melissa Malivoire, David Ellwood, Vicki Flenady
Paracetamol in Pregnancy: Uncertain Evidence, Certain Consequences
David J. Tunnicliffe, Miranda Cumpston, Debra Kennedy, Margie Danchin, Armando Teixeira-Pinto
Fatty Liver Disease in Australia: A Narrative Review on the Epidemiology, Natural History, Prognostication and Management in People With Metabolic Dysfunction
Karl Vaz, Daniel Clayton-Chubb, William W. Kemp, Stuart K. Roberts, Ammar Majeed
Birth prevalence, clinical sequelae, and management of congenital cytomegalovirus infections in Australia, 1999–2023: a national prospective study
Ece Egilmezer, Suzy M Teutsch, Carlos Nunez, Stuart T Hamilton, Adam W Bartlett, Pamela Palasanthiran, Elizabeth J Elliott, William D Rawlinson
The number of cancer‐related deaths that could be attributable to spatial disparities in survival in Australia, 2010–2019: a retrospective population‐based cohort study
Charlotte K Bainomugisa, Jessica Cameron, Paramita Dasgupta, Peter Baade
Mandatory research projects during medical specialist training in Australia and New Zealand
Paulina Stehlik, Caitlin Brandenburg, David A Henry